#cipla — Public Fediverse posts

Cipla Reports Mixed Fiscal Signals Amidst India Focus

Cipla's FY26 earnings calls reveal a strong focus on the Indian market. Find out what this means for investors and the company's future.

#Cipla #IndianMarket #EarningsCall #PharmaNews #FY26

https://newsletter.tf/cipla-fy26-earnings-calls-india-market-focus/

Cipla's earnings calls from July 2025 to April 2026 show a repeated focus on the Indian market, with calls covering Q1 FY26, Q4 FY25, and Q4 FY26.

#Cipla #IndianMarket #EarningsCall #PharmaNews #FY26
https://newsletter.tf/cipla-fy26-earnings-calls-india-market-focus/

30 stocks to watch: Tata Motors, M&M, Brigade, HAL, Digilogic, Natco Pharma, Cipla

https://misryoum.com/us/markets/30-stocks-to-watch-tata-motors-mm-brigade/

Ola Electric has announced that its Roadster range now starts at just ₹79,999. This brings electric motorcycles directly at par with popular entry-segment ICE motorcycles. The company’s Roadster X portfolio comes in 2.5 kWh, 3.5 kWh and 4.5 kWh configurations,...

#stocks #watch #Tata #Motors #Brigade #HAL #Digilogic #Natco #Pharma #Cipla #US_News_Hub #misryoum_com

Stocks to Watch for March 4: ONGC, HPCL, Petronet, IGL, Cipla, Tata Motors CV, M&M and more

https://misryoum.com/us/markets/stocks-to-watch-for-march-4-ongc-hpcl/

1 / 12Oil Sensitives | Oil sensitive stocks will continue to remain in focus during Wednesday's trading session as well with Brent Crude climbing back above the mark of $80 per barrel. Although ONGC and Oil India did not see...

#Stocks #Watch #for #March #ONGC #HPCL #Petronet #IGL #Cipla #Tata #Motors #and #more #US_News_Hub #misryoum_com

South Africa ‘can’t afford’ to pay for new anti-HIV drug, despite cut-price offer | Global development | The Guardian
https://www.theguardian.com/global-development/2023/nov/17/south-africa-hiv-cab-la-cabotegravir-viiv-healthcare

#SouthAfrica
#HIV
#AntiHIVDrug
#Cabotegravir
#CABLA
#Pepfar
#ViiV
#Cipla

South Africa ‘can’t afford’ to pay for new anti-HIV drug, despite cut-price offer | Global development | The Guardian
https://www.theguardian.com/global-development/2023/nov/17/south-africa-hiv-cab-la-cabotegravir-viiv-healthcare

#SouthAfrica
#HIV
#AntiHIVDrug
#Cabotegravir
#CABLA
#Pepfar
#ViiV
#Cipla